ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/5/2022ACC: 0001209191-22-040789
Officer· Interim CFO
Since Jun 2021
-354.00
Net shares
Net seller
$137.71
Total sold
0
Open market trades
0B · 0S
1
Total transactions
354.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−354.00
Price / share
$0.39
Trade value
$137.71
% of position
0.2%
6/30/2022
174.07K→173.71K
Total
Net shares
−354.00
Net value
-$137.71
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2022 | F · Tax Withholding | −354.00 | $0.39 | $137.71 | 0.2% | 174.07K | 173.71K |
| Total | −354.00 | -$137.71 | ||||||
Derivative Transactions0
No derivative transactions reported